Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers, non-manifesting carriers and related daughters

Clinical Genetics

Volumn 84, Issue 3, 2013, Pages 265-270

  Viggiano, E ^a   Picillo, E ^a   Cirillo, A ^b   Politano, L ^a  

^a Cardiomyology and Medical Genetics ^*  (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

DMD carriers; Dystrophin gene; Skewed X inactivation; X inactivation

Indexed keywords

ANDROGEN RECEPTOR; DNA; DYSTROPHIN; GENOMIC DNA;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DAUGHTER; DNA DETERMINATION; DNA EXTRACTION; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; LYMPHOCYTE; MUSCLE WEAKNESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METHYLATION; X CHROMOSOME INACTIVATION;

DMD CARRIERS; DYSTROPHIN GENE; SKEWED X-INACTIVATION; X-INACTIVATION;

ADOLESCENT; ADULT; AGED; CHILD; DYSTROPHIN; FEMALE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; PHENOTYPE; X CHROMOSOME INACTIVATION; YOUNG ADULT;

EID: 84881611731     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12048     Document Type: Article

References (28)

1. Moser H, Emery AE. The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 1974: 5: 271-284.
2. Norman A, Harper P. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales. Clin Genet 1989: 36: 31-37.
3. Emery AEH. Duchenne muscular dystrophy, 2nd edn. New York, NY: Oxford University Press, 1993.
4. Seemann N, Selby K, McAdam L et al. Canadian Pediatric Neuromuscular Group. Symptomatic dystrophinopathies in female children. Neuromuscul Disord 2011: 21: 172-177.
5. Politano L, Nigro G. Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol 2012: XXXI: 24-30.
6. Comi LI, Nigro G, Politano L, Petretta VR. The cardiomyopathy of Duchenne/Becker consultands. Int J Cardiol 1992: 34 (3): 297-305.
7. Nigro G, Di Somma S, Comi LI et al. Structural basis of cardiomyopathy in Duchenne/Becker carriers. Endomyocardial biopsy evaluation. Ann N Y Acad Sci 1995: 752: 108-110.
8. Politano L, Nigro V, Nigro G et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996: 275: 1335-1338.
9. Mirabella M, Servidei S, Manfredi G et al. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology 1993: 43: 2342-2345.
10. Nigro G, Comi LI, Politano L, Nigro G. Cardiomyopathies associated with Muscular Dystrophies. In: Engel A, Franzini-Armstrong C, eds. Myology. New York, NY: Mac Graw-Hill, 2004: 1239-1256.
11. Hoogerwaard EM, Bakker E, Ippel PF et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999: 353: 2116-2119.
12. Azofeifa J, Voit T, Hübner C et al. X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes. Hum Genet 1995: 96: 167-176.
13. Bushby KM, Goodship JA, Nicholson LV et al. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1993: 3: 57-64.
14. Tihy F, Vogt N, Recan D et al. Skewed inactivation of an X-chromosome deleted at the dystrophin gene in an asymptomatic mother and her affected daughter. Hum Genet 1994: 93: 563-567.
15. Yoshioka M, Yorifuji T, Mituyoshi I. Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy. Clin Genet 1998: 53: 102-107.
16. Richards CS, Watkins SC, Hoffman EP et al. Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy. Am J Hum Genet 1990: 46: 672-681.
17. Lupski JR, Garcia CA, Zoghbi HY et al. Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy. Am J Med Genet 1991: 40: 354-364.
18. Soltanzadeh P, Friez MJ, Dunn D et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord 2010: 20: 499-504.
19. Matthews PM, Benjamin D, Van Bakel I et al. Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers. Neuromuscul Disord 1995: 5: 209-220.
20. Carsana A, Frisso G, Intrieri M et al. A 15-year molecular analysis of DMD/BMD: genetic features in a large cohort. Front Biosci (Elite Ed) 2010: 2: 547-558.
21. Yoon J, Kim SH, Ki CS et al. Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis. J Korean Med Sci 2011: 26: 587-591.
22. Sumita DR, Vainzof M, Campiotto S et al. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers. Am J Med Genet 1998: 80: 356-361.
23. Brioschi S, Gualandi F, Scotton C et al. Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype. BMC Med Genet 2012: 13: 73.
24. Allen RC, Zoghbi HY, Moseley AB et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet 1992: 51: 1229-1239.
25. Kyriakides T, Pegoraro E, Hoffman EP et al. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment. Neurology 2011: 77: 1858-1859.
26. Pegoraro E, Schimke RN, Garcia C et al. Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology 1995: 45 (4): 677-690.
27. Azofeifa J, Waldherr R, Cremer M. X-chromosome methylation ratios as indicators of chromosomal activity: evidence of intraindividual divergencies among tissues of different embryonal origin. Hum Genet 1996: 97 (3): 330-333.
28. Sharp A, Robinson D, Jacobs P. Age- and tissue-specific variation of X-chromosome inactivation ratios in normal women. Hum Genet 2000: 107: 343-349.